Ligand id: 9161

Name: ulocuplumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9854 ulocuplumab
BMS-936564 | MDX-1338
Ulocuplumab is an IgG4 kappa anti-CXCR4 monoclonal, being developed by Bristol-Myers Squibb as a potential oncolgy therapeutic.
Peptide sequences and structural details for this antibody are available from its IMGT/mAb-DB record.
BLAST sequence analysis of the heavy and light chain peptide sequences of ulocuplumab, reveal identical matches with sequences claimed in patent US8450464 [5]. This identifies clone F7GL as the likely candidate for ulocuplumab.
Database Links
Specialist databases
IMGT/mAb-DB 483
Other databases
GtoPdb PubChem SID 315661244
Search PubMed clinical trials ulocuplumab
Search PubMed titles ulocuplumab
Search PubMed titles/abstracts ulocuplumab